Literature DB >> 24707332

Advances in epilepsy in 2013 for the neurohospitalist.

Andrew Nathan Wilner1.   

Abstract

Entities:  

Keywords:  autoimmune diseases of the nervous system; central nervous system infections; clinical specialty; encephalitis; epilepsy; experimental; nervous system autoimmune disease; seizures; status epilepticus

Year:  2014        PMID： 24707332      PMCID： PMC3975799          DOI： 10.1177/1941874414525177

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN： 1941-8744


× No keyword cloud information.
  8 in total

1.  A proposed roadmap for inpatient neurology quality indicators.

Authors:  Vanja C Douglas; S Andrew Josephson
Journal:  Neurohospitalist       Date:  2011-01

Review 2.  Encephalitis and antibodies to synaptic and neuronal cell surface proteins.

Authors:  Eric Lancaster; Eugenia Martinez-Hernandez; Josep Dalmau
Journal:  Neurology       Date:  2011-07-12       Impact factor: 9.910

3.  Responsive cortical stimulation for the treatment of medically intractable partial epilepsy.

Authors:  Martha J Morrell
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

4.  Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study.

Authors:  Raoul Sutter; Stephan Marsch; Peter Fuhr; Stephan Rüegg
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

5.  Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies.

Authors:  António Gil-Nagel; Christian Elger; Elinor Ben-Menachem; Peter Halász; José Lopes-Lima; Alberto A Gabbai; Teresa Nunes; Amílcar Falcão; Luis Almeida; Patrício Soares da-Silva
Journal:  Epilepsia       Date:  2012-08-06       Impact factor: 5.864

6.  Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.

Authors:  Nicolas Gaspard; Brandon Foreman; Lilith M Judd; James N Brenton; Barnett R Nathan; Blathnaid M McCoy; Ali Al-Otaibi; Ronan Kilbride; Ivan Sánchez Fernández; Lucy Mendoza; Sophie Samuel; Asma Zakaria; Giridhar P Kalamangalam; Benjamin Legros; Jerzy P Szaflarski; Tobias Loddenkemper; Cecil D Hahn; Howard P Goodkin; Jan Claassen; Lawrence J Hirsch; Suzette M Laroche
Journal:  Epilepsia       Date:  2013-06-12       Impact factor: 5.864

7.  Efficacy and safety of ketamine in refractory status epilepticus in children.

Authors:  Anna Rosati; Manuela L'Erario; Lucrezia Ilvento; Costanza Cecchi; Tiziana Pisano; Lorenzo Mirabile; Renzo Guerrini
Journal:  Neurology       Date:  2012-11-28       Impact factor: 9.910

8.  Autoimmune encephalitis: A potentially reversible cause of status epilepticus, epilepsy, and cognitive decline.

Authors:  Awadh Kishor Pandit; Kavish Ihtisham; Ajay Garg; Sheffali Gulati; Madakasira Vasantha Padma; Manjari Tripathi
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383
  8 in total
  1 in total

1.  Commentary.

Authors:  Hossam Sanyelbhaa Talaat
Journal:  J Neurosci Rural Pract       Date:  2015-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.